Literature DB >> 33525678

Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma.

Imran Khan1, Mohammad Hassan Baig2, Sadaf Mahfooz1, Moniba Rahim3, Busra Karacam1, Elif Burce Elbasan4, Ilya Ulasov5, Jae-June Dong2, Mustafa Aziz Hatiboglu1,4.   

Abstract

Autophagy is a process essential for cellular energy consumption, survival, and defense mechanisms. The role of autophagy in several types of human cancers has been explicitly explained; however, the underlying molecular mechanism of autophagy in glioblastoma remains ambiguous. Autophagy is thought to be a "double-edged sword", and its effect on tumorigenesis varies with cell type. On the other hand, autophagy may play a significant role in the resistance mechanisms against various therapies. Therefore, it is of the utmost importance to gain insight into the molecular mechanisms deriving the autophagy-mediated therapeutic resistance and designing improved treatment strategies for glioblastoma. In this review, we discuss autophagy mechanisms, specifically its pro-survival and growth-suppressing mechanisms in glioblastomas. In addition, we try to shed some light on the autophagy-mediated activation of the cellular mechanisms supporting radioresistance and chemoresistance in glioblastoma. This review also highlights autophagy's involvement in glioma stem cell behavior, underlining its role as a potential molecular target for therapeutic interventions.

Entities:  

Keywords:  autophagy; chemoresistance; glioblastoma; glioma stem cells; molecular targets; radioresistance

Year:  2021        PMID: 33525678      PMCID: PMC7865981          DOI: 10.3390/ijms22031318

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  212 in total

1.  Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes.

Authors:  Andrew R J Young; Edmond Y W Chan; Xiao Wen Hu; Robert Köchl; Samuel G Crawshaw; Stephen High; Dale W Hailey; Jennifer Lippincott-Schwartz; Sharon A Tooze
Journal:  J Cell Sci       Date:  2006-08-29       Impact factor: 5.285

2.  Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death.

Authors:  Jong-Ok Pyo; Mi-Hee Jang; Yun-Kyung Kwon; Ho-June Lee; Joon-Il Jun; Ha-Na Woo; Dong-Hyung Cho; Boyoun Choi; Heuiran Lee; Joo-Hang Kim; Noboru Mizushima; Yoshinori Oshumi; Yong-Keun Jung
Journal:  J Biol Chem       Date:  2005-03-18       Impact factor: 5.157

3.  Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.

Authors:  Galia Tiram; Shiran Ferber; Paula Ofek; Anat Eldar-Boock; Dikla Ben-Shushan; Eilam Yeini; Adva Krivitsky; Roni Blatt; Nava Almog; Jack Henkin; Orit Amsalem; Eylon Yavin; Gadi Cohen; Philip Lazarovici; Joo Sang Lee; Eytan Ruppin; Michael Milyavsky; Rachel Grossman; Zvi Ram; Marcelo Calderón; Rainer Haag; Ronit Satchi-Fainaro
Journal:  FASEB J       Date:  2018-06-01       Impact factor: 5.191

Review 4.  A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments.

Authors:  Kenta Masui; Beatrice Gini; Jill Wykosky; Ciro Zanca; Paul S Mischel; Frank B Furnari; Webster K Cavenee
Journal:  Carcinogenesis       Date:  2013-03-01       Impact factor: 4.944

5.  DDR1 (discoidin domain receptor tyrosine kinase 1) drives glioblastoma therapy resistance by modulating autophagy.

Authors:  Anne Vehlow; Nils Cordes
Journal:  Autophagy       Date:  2019-05-23       Impact factor: 16.016

6.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

7.  Depletion of Beclin-1 due to proteolytic cleavage by caspases in the Alzheimer's disease brain.

Authors:  Troy T Rohn; Ellen Wirawan; Raquel J Brown; Jordan R Harris; Eliezer Masliah; Peter Vandenabeele
Journal:  Neurobiol Dis       Date:  2010-11-21       Impact factor: 5.996

8.  NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro.

Authors:  Wen-juan Wang; Lin-mei Long; Neng Yang; Qing-qing Zhang; Wen-jun Ji; Jiang-hu Zhao; Zheng-hong Qin; Zhong Wang; Gang Chen; Zhong-qin Liang
Journal:  Acta Pharmacol Sin       Date:  2013-04-22       Impact factor: 6.150

9.  A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.

Authors:  Myrna R Rosenfeld; Xiaobu Ye; Jeffrey G Supko; Serena Desideri; Stuart A Grossman; Steven Brem; Tom Mikkelson; Daniel Wang; Yunyoung C Chang; Janice Hu; Quentin McAfee; Joy Fisher; Andrea B Troxel; Shengfu Piao; Daniel F Heitjan; Kay-See Tan; Laura Pontiggia; Peter J O'Dwyer; Lisa E Davis; Ravi K Amaravadi
Journal:  Autophagy       Date:  2014-05-20       Impact factor: 16.016

10.  Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma.

Authors:  Wei Wu; Yang Wu; Karoline Mayer; Charlotte von Rosenstiel; Johannes Schecker; Sandra Baur; Sylvia Würstle; Friederike Liesche-Starnecker; Jens Gempt; Jürgen Schlegel
Journal:  Transl Oncol       Date:  2020-02-19       Impact factor: 4.243

View more
  5 in total

Review 1.  Cell Biology Meets Cell Metabolism: Energy Production Is Similar in Stem Cells and in Cancer Stem Cells in Brain and Bone Marrow.

Authors:  Cornelis J F van Noorden; Barbara Breznik; Metka Novak; Amber J van Dijck; Saloua Tanan; Miloš Vittori; Urban Bogataj; Noëlle Bakker; Joseph D Khoury; Remco J Molenaar; Vashendriya V V Hira
Journal:  J Histochem Cytochem       Date:  2021-10-29       Impact factor: 2.479

Review 2.  Repurposing autophagy regulators in brain tumors.

Authors:  Edgar Petrosyan; Jawad Fares; Alex Cordero; Aida Rashidi; Víctor A Arrieta; Deepak Kanojia; Maciej S Lesniak
Journal:  Int J Cancer       Date:  2022-03-04       Impact factor: 7.316

3.  Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells.

Authors:  Luca X Zampieri; Martina Sboarina; Andrea Cacace; Debora Grasso; Léopold Thabault; Loïc Hamelin; Thibaut Vazeille; Elodie Dumon; Rodrigue Rossignol; Raphaël Frédérick; Etienne Sonveaux; Florence Lefranc; Pierre Sonveaux
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

4.  Immunoexpression of p62/SQSTM1/Sequestosome-1 in human primary and recurrent IDH1/2 wild-type glioblastoma: A pilot study.

Authors:  Antonio Ieni; Cristina Pizzimenti; Giuseppe Broggi; Rosario Caltabiano; Antonino Germanò; Giuseppe Maria Vincenzo Barbagallo; Paolo Vigneri; Giuseppe Giuffrè; Giovanni Tuccari
Journal:  Oncol Lett       Date:  2022-08-11       Impact factor: 3.111

Review 5.  Autophagy in Xp11 translocation renal cell carcinoma: from bench to bedside.

Authors:  Huimin Sun; Xing Wei; Changchun Zeng
Journal:  Mol Cell Biochem       Date:  2021-08-03       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.